Heterogeneity of Circulating Tumor Cells in Neoadjuvant Chemotherapy of Breast Cancer

Heterogeneity of Circulating Tumor Cells in Neoadjuvant Chemotherapy of Breast Cancer

The biological properties of circulating tumor cells (CTCs), and their dynamics during neoadjuvant chemotherapy are important, both for disease progression prediction and therapeutic target determination, with the aim of preventing disease progression. The aim of our study was to estimate of differe...

Full description

Bibliographic Details
Main Authors:	Evgeniya V. Kaigorodova, Olga E. Savelieva, Liubov A. Tashireva, Natalia A. Tarabanovskaya, Elena I. Simolina, Evgeny V. Denisov, Elena M. Slonimskaya, Evgeny L. Choynzonov, Vladimir M. Perelmuter
Format:	Article
Language:	English
Published:	MDPI AG 2018-03-01
Series:	Molecules
Subjects:	heterogeneity of circulating tumor cells EMT EpCAM-negative circulating tumor cells NACT breast cancer
Online Access:	http://www.mdpi.com/1420-3049/23/4/727

Similar Items

Circulating tumor cells: the substrate of personalized medicine?
by: Bryan eGreene, et al.
Published: (2012-07-01)

Circulating Tumor Cells Adhesion: Application in Biosensors
by: Eduarda B. Paglia, et al.
Published: (2023-09-01)

Heterogeneity of Stemlike Circulating Tumor Cells in Invasive Breast Cancer
by: Olga E. Savelieva, et al.
Published: (2020-04-01)

Polycarboxybetaine-Based Hydrogels for the Capture and Release of Circulating Tumor Cells
by: Hsiu-Wen Chien, et al.
Published: (2022-06-01)

Heterogeneous Manifestations of Epithelial–Mesenchymal Plasticity of Circulating Tumor Cells in Breast Cancer Patients
by: Liubov A. Tashireva, et al.
Published: (2021-03-01)

In Vivo Enrichment and Elimination of Circulating Tumor Cells by Using a Black Phosphorus and Antibody Functionalized Intravenous Catheter
by: Dou Wang, et al.
Published: (2020-09-01)

The value of circulating tumor cells with positive centromere probe 8 in the diagnosis of small pulmonary nodules
by: Caidong Liu, et al.
Published: (2021-05-01)

Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis
by: Ana M.C. Barradas, et al.
Published: (2013-12-01)

Comparison of circulating tumor cell (CTC) detection rates with epithelial cell adhesion molecule (EpCAM) and cell surface vimentin (CSV) antibodies in different solid tumors: a retrospective study
by: Yang Gao, et al.
Published: (2021-03-01)

An Immune–Magnetophoretic Device for the Selective and Precise Enrichment of Circulating Tumor Cells from Whole Blood
by: Chaithanya Chelakkot, et al.
Published: (2020-05-01)

Detection of circulating tumor cells in non-small cell lung cancer
by: Annkathrin eHanssen, et al.
Published: (2015-09-01)

Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease
by: Annkathrin Hanssen, et al.
Published: (2018-12-01)

Circulating Tumor Cell Models Mimicking Metastasizing Cells In Vitro: Discrimination of Colorectal Cancer Cells and White Blood Cells Using Digital Holographic Cytometry
by: Marek Feith, et al.
Published: (2022-12-01)

Photo-functionalized TiO2 film for facile immobilization of EpCAM antibodies and efficient enrichment of circulating tumor cells
by: Huan Deng, et al.
Published: (2023-02-01)

Single Tumor Cells With Epithelial-Like Morphology Are Associated With Breast Cancer Metastasis
by: Liubov A. Tashireva, et al.
Published: (2020-02-01)

Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition
by: Taylor C. Brown, et al.
Published: (2021-06-01)

Absence of EpCAM in cervical cancer cells is involved in sluginduced epithelial‐mesenchymal transition
by: Xian Liu, et al.
Published: (2021-03-01)

Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas
by: Henrik Schinke, et al.
Published: (2021-04-01)

Membrane Hsp70—A Novel Target for the Isolation of Circulating Tumor Cells After Epithelial-to-Mesenchymal Transition
by: Stephanie Breuninger, et al.
Published: (2018-11-01)

Integrin-associated transcriptional characteristics of circulating tumor cells in breast cancer patients
by: Evgeniya Grigoryeva, et al.
Published: (2024-01-01)

Development of DNA Aptamers to Native EpCAM for Isolation of Lung Circulating Tumor Cells from Human Blood
by: Galina S. Zamay, et al.
Published: (2019-03-01)

Classification of Cells in CTC-Enriched Samples by Advanced Image Analysis
by: Sanne de Wit, et al.
Published: (2018-10-01)

The Novel Association of Early Apoptotic Circulating Tumor Cells with Treatment Outcomes in Breast Cancer Patients
by: Evgeniya S. Grigoryeva, et al.
Published: (2022-08-01)

EpCAM (CD326) Regulates Intestinal Epithelial Integrity and Stem Cells via Rho-Associated Kinase
by: Takeshi Ouchi, et al.
Published: (2021-01-01)

Targeting EpCAM by a Bispecific Trifunctional Antibody Exerts Profound Cytotoxic Efficacy in Germ Cell Tumor Cell Lines
by: Stefan Schönberger, et al.
Published: (2020-05-01)

Clinicopathological and prognostic value of epithelial cell adhesion molecule in solid tumours: a meta-analysis
by: Peiwen Ding, et al.
Published: (2023-08-01)

Oncolytic vaccinia virus expressing a bispecific T-cell engager enhances immune responses in EpCAM positive solid tumors
by: Min Wei, et al.
Published: (2022-11-01)

Genetic profiling of different phenotypic subsets of breast cancer stem cells (BCSCs) in breast cancer patients
by: Abdel-Rahman N. Zekri, et al.
Published: (2022-12-01)

Removal of EpCAM-positive tumor cells from blood collected during major oncological surgery using the Catuvab device- a pilot study
by: Andreas Winter, et al.
Published: (2021-10-01)

The Value of Circulating Tumor Cells in the Prognosis and Treatment of Pancreatic Cancer
by: Kai Luo, et al.
Published: (2022-07-01)

Characteristics of Extracellular Vesicles from a High-Grade Serous Ovarian Cancer Cell Line Derived from a Platinum-Resistant Patient as a Potential Tool for Aiding the Prediction of Responses to Chemotherapy
by: Katarina Černe, et al.
Published: (2023-06-01)

EpCAM as a novel therapeutic target for hepatocellular carcinoma
by: Vasanthakumar S, et al.
Published: (2017-07-01)

The Association of Integrins β3, β4, and αVβ5 on Exosomes, CTCs and Tumor Cells with Localization of Distant Metastasis in Breast Cancer Patients
by: Evgeniya S. Grigoryeva, et al.
Published: (2023-02-01)

Tumor-Derived Exosomes Regulate Apoptosis of CD45+EpCAM+ Cells in Lung Cancer
by: Shixiang Lu, et al.
Published: (2022-05-01)

Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma
by: Jong Jin Sung, et al.
Published: (2016-01-01)

Fraction of MHCII and EpCAM expression characterizes distal lung epithelial cells for alveolar type 2 cell isolation
by: Koichi Hasegawa, et al.
Published: (2017-08-01)

Recent advances of bispecific antibodies in solid tumors
by: Shengnan Yu, et al.
Published: (2017-09-01)

Fast and selective cell isolation from blood sample by microfiber fabric system with vacuum aspiration
by: Takayuki Ueki, et al.
Published: (2016-01-01)

Destabilization of EpCAM dimer is associated with increased susceptibility towards cleavage by TACE
by: Tomaž Žagar, et al.
Published: (2021-05-01)

Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy
by: Weizhen Li, et al.
Published: (2021-11-01)